StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / nucleix.com

Nucleix

Nucleix (nucleix.com): 2 changes recorded in its website history since July 2016. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. ComplianceBetween and

    Now states CE-MARKED compliance on its homepage.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  2. New logosBetween and

    Added logos to its homepage: Untitled2 and Untitled3.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 30 July 2016

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Using Epigenetics for Cancer Detection in Liquid Biopsy | Nucleix

EpiCheck is a highly innovative product for detection of cancer in liquid biopsy samples, using a panel of various methylation biomarkers

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. July 2016 – August 2022 · 5 captures · latest observed messagingUsing Epigenetics for Cancer Detection in Liquid Biopsy | Nucleix

    EpiCheck is a highly innovative product for detection of cancer in liquid biopsy samples, using a panel of various methylation biomarkers

    This wording observed 16 August 2022.

    archived page
    Inspect 5 captures in this group
    • 30 July 2016 · Using Epigenetics for Cancer Detection in Liquid Biopsy | Nucleix archived page
    • 11 February 2018 · Using Epigenetics for Cancer Detection in Liquid Biopsy | Nucleix archived page
    • 16 June 2020 · Using Epigenetics for Cancer Detection in Liquid Biopsy | Nucleix archived page
    • 20 January 2021 · Using Epigenetics for Cancer Detection in Liquid Biopsy | Nucleix archived page
    • 16 August 2022 · Using Epigenetics for Cancer Detection in Liquid Biopsy | Nucleix archived page
Summary of the record · AI-written

Written by an AI model on 7 November 2026 from the dated observations above; this is not the date the changes happened; each point links to the changes it rests on.

Nucleix adds logos and states CE-MARKED compliance

Nucleix added new logos to its homepage and later started stating CE-MARKED compliance on its homepage. These site updates may reflect positioning of its offerings in regulated markets.

  • Between June 2020 and January 2021, Nucleix added logos to its homepage: Untitled2 and Untitled3. [1]
  • Between August 2022 and January 2024, Nucleix started stating CE-MARKED compliance on its homepage. [2]
  • Reading: The statement of CE-MARKED compliance on the homepage between August 2022 and January 2024 suggests Nucleix may be emphasizing regulatory status in its public positioning. [2]

Cite this record

StartupHistory, “Nucleix” company record, https://startuphistory.org/c/nucleix.com

Machine-readable: /c/nucleix.com.json. How changes are found: method.